Climb Bio Inc share price logo

Climb Bio Inc Share Price

NASDAQ: CLYM

Small Cap

$2.12

+0.11

(+5.47%)

as on

Climb Bio Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.04
    $2.19
    downward going graph

    3.77%

    Downside

    3.30%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.05
    $5.86
    downward going graph

    50.47%

    Downside

    176.42%

    Upside

    downward going graph

Climb Bio Inc share price movements today

Previous Close
$2.01
Open
$2.05
Volume
1.0M
Day's Low - High
$2.04 - $2.19
52 Week Low - High
$1.05 - $5.86

Climb Bio Inc Historical Returns

1 Month Return
+ 5.79 %
3 Month Return
+ 67.5 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Climb Bio Inc Stock Fundamentals & Key Indicators

Check Climb Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$138.2M

EPS (TTM)

-0.7425

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

38179400.00%

Climb Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Climb Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Climb Bio Inc image
Climb Bio Inc
NA$138.2MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$60.5B252.04%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$39.0BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$100.3B44.17%27.8531.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.6B1.78%14.131.37%

Climb Bio Inc Stock's Interest Amongst Investors

Search interest for Climb Bio Inc Stock has decreased by -72% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-72% versus previous 30 day period

Climb Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
0
Operating Income
-6
-5
-5
-3
-56
-11
-10
-23
-10
EBITDA
-6
-5
-5
-3
-56
-11
-10
-23
-8
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-5
-3
-3
-1
-54
-8
-8
-20
-8
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-5
-3
-3
-1
-54
-8
-8
-20
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Climb Bio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Income
-20
-35
-45
-40
-82
EBITDA
-11
-35
-45
-40
-30
Interest Expense
-
-
-
-
-
Depreciation
-
-
-
-
-
Income Before Tax
-20
-47
-45
-35
-73
Income Tax Expense
-
-
-
-
-
Net Income
-20
-47
-45
-35
-73
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Climb Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-5
-3
-3
-1
-54
-8
-8
-20
-8
Operating Cash Flow
-7
3
0
-1
0
-7
-5
-15
-11
Investing Cash Flow
-1
28
36
13
-9
-71
-53
-42
4
Financing Cash Flow
0
0
0
0
128
2
0
-
-
Change in Cash
-9
32
35
11
118
-76
-58
-58
-6

Climb Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-20
-47
-45
-35
-73
Operating Cash Flow
-14
-36
-37
-20
-15
Investing Cash Flow
8
-114
34
68
-121
Financing Cash Flow
4
177
-
0
130
Change in Cash
0
26
-3
49
-5

Insights on Climb Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 143.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 155.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CLYM stock has moved down by -16.3%

About Climb Bio Inc

Climb Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics for patients with immune-mediated diseases. The Company’s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody designed to deplete CD19-positive B cells, including antibody-secreting cells, in order to directly reduce pathogenic autoantibodies. The reduction of autoantibodies has the potential to be disease-modifying in autoantibody-driven diseases, such as systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. The budoprutug is in a Phase Ib/IIa clinical trial. The Company is also developing CLYM116, an anti-APRIL antibody, in investigational new drug applications (IND)-enabling studies for IgA nephropathy (IgAN).
OrganisationClimb Bio Inc
Headquarters20 William Street, Wellesley Hills, MA, United States, 02481
CEODr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
E-voting on sharesClick here to vote

Key Management of Climb Bio Inc

Name

Title

Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc

Interim Principal Financial Officer, CEO, President & Director

Ms. Chandra Adams J.D.

VP & General Counsel

FAQs

What is Climb Bio Inc share price today?

Climb Bio Inc share price today is $2.12 as on at the close of the market. Climb Bio Inc share today touched a day high of $2.19 and a low of $2.04.

What is the 52 week high and 52 week low for Climb Bio Inc share?

Climb Bio Inc share touched a 52 week high of $5.86 on and a 52 week low of $1.05 on . Climb Bio Inc stock price today i.e. is closed at $2.12,which is 63.82% down from its 52 week high and 101.90% up from its 52 week low.

What is Climb Bio Inc's market capitalisation today?

Climb Bio Inc market capitalisation is $0.00T as on .

How to invest in Climb Bio Inc Stock (CLYM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Climb Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Climb Bio Inc Shares that will get you 0.7075 shares as per Climb Bio Inc share price of $2.12 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Climb Bio Inc Stock (CLYM) from India?

Indian investors can start investing in Climb Bio Inc (CLYM) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Climb Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Climb Bio Inc share’s latest price of $2.12 as on September 18, 2025 at 1:29 am IST, you will get 4.7170 shares of Climb Bio Inc. Learn more about fractional shares .